Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1128533

	registered interest
	date	23/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pancreatitis: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS Long Term Plan, what plans the Government has to allocate funding for research into chronic pancreatitis.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257709
	answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>The NHS Long Term Plan is a 10-year strategy for the National Health Service. It sets out how the NHS will spend the £33.9 billion cash terms annual increase going into the NHS budget by 2023/24. Research on health and social care continues to be funded by the Government through the National Institute for Health Research (NIHR). The future of budgets outside of the NHS England resource settlement will be confirmed later this year at Spending Review 2019.</p><p>The NIHR welcomes funding applications for research into any aspect of human health, including chronic pancreatitis. As with other major research funders, the NIHR does not ring-fence funds for particular topics or conditions. Applications for funding are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p><br> The NIHR’s funding and support for research into chronic pancreatitis which is currently ongoing or recently concluded (in financial year 2018/19) includes one directly funded study, with a total award of £262,500, investigating the use of antioxidants and magnesium for the treatment of pain in hereditary and idiopathic chronic pancreatitis. In addition, there has been NIHR support for two studies through its early translational research infrastructure and five through the NIHR’s Clinical Research Network, which provides support for delivering research funded by the NIHR itself and other public, charity and industry research funders.</p><p> </p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 05/06/2019 16:26:33 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1533 label Biography information for Dame Diana Johnson

1128536

	registered interest
	date	23/05/2019
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	Transport: North of England
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, what the (a) start and (b) end dates are for his Department's investment programmes for transport in the north by 2020.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257710
	answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>The Government funds a wide range of transport investment in the North. The start and end dates of the main transport programmes which will benefit the North by 2020 are as follows:</p><table><tbody><tr><td><p>Roads Investment Fund</p></td><td><p>2015/16 to 2019/20</p></td></tr><tr><td><p>Rail investment in Control Period 5</p></td><td><p>2014/15 to 2018/19</p></td></tr><tr><td><p>Rail investment in Control Period 6</p></td><td><p>2019/20 to 2023/24</p></td></tr><tr><td><p>Large Local Majors Funding</p></td><td><p>2015/16 to 2020/21</p></td></tr><tr><td><p>Transforming Cities Fund</p></td><td><p>2018/19 to 2022/23</p></td></tr><tr><td><p>Future Mobility Zones</p></td><td><p>2018/19 to 2022/23</p></td></tr><tr><td><p>Local Growth Funding</p></td><td><p>2015/16 to 2020/21</p></td></tr><tr><td><p>Integrated Transport Block</p></td><td><p>2015/16 to 2020/21</p></td></tr><tr><td><p>Highways Maintenance Fund</p></td><td><p>2015/16 to 2020/21</p></td></tr></tbody></table> answering member constituency Northampton North answering member printed Michael Ellis question first answered 05/06/2019 12:33:11 answering member 4116 label Biography information for Sir Michael Ellis
	tabling member	1533 label Biography information for Dame Diana Johnson

1128423

	registered interest
	date	22/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases: Life Expectancy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of trends in the life expectancy of patients with sickle cell disease since 2000; and what steps he is taking to increase life expectancy for people suffering from that disease.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257501
	answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>Evidence suggests that life expectancy for people with sickle cell disease is improving. This is due to a number of factors including;</p><p>- Improved new born screening coverage to enable earlier diagnosis;</p><p>- Use of the National Haemoglobinopathy Registry to monitor individuals’ health, treatment and their annual reviews;</p><p>- Access to specific diagnostics and medication, such as hydroxyurea; and</p><p>- A Commissioning for Quality and Innovation incentive has been in place for the last two years to improve access to apheresis for individuals with sickle cell disease.</p><p>These factors are reflected in NHS England’s service specification quality indicators which providers are required to report against so that implementation can be monitored.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 05/06/2019 14:30:29 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1533 label Biography information for Dame Diana Johnson

1128424

	registered interest
	date	22/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dementia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to engage with people affected by dementia on the development of the liberty protection safeguards code of practice.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257502
	answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>The Department is currently collaborating closely with stakeholders, including those with lived experience, to produce the Liberty Protection Safeguards Code of Practice. It is engaging with the third sector, health and social care organisations, user-led groups and individuals. This includes organisations which represent individuals with dementia and those affected by it, for example the Alzheimer’s Society and Carers UK.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 05/06/2019 13:45:32 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1533 label Biography information for Dame Diana Johnson

1128425

	registered interest
	date	22/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pancreatitis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the number of people living with a diagnosis of chronic pancreatitis.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257503
	answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>No estimate has been made. However, the National Institute for Health and Care Excellence (NICE), in its guidance ‘Pancreatitis’, published September 2018, states that the annual incidence of chronic pancreatitis in western Europe is about five cases per 100,000 people. The male to female ratio is 7:1 and the average age of onset is between 36 and 55. The NICE guideline can be found at the following link:</p><p><a href="http://www.nice.org.uk/guidance/ng104" target="_blank">www.nice.org.uk/guidance/ng104</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 05/06/2019 14:16:47 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1533 label Biography information for Dame Diana Johnson

1127722

	registered interest
	date	21/05/2019
	answering body	Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	Treasury
	hansard heading	Productivity
	house id	1
	legislature	25259 pref label House of Commons
	question text	What fiscal steps his Department is taking to increase regional productivity.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	911025
	answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The Government is investing in every region to drive jobs and growth, with 3.5 million more people in work since 2010. <br></p><p>Investments include the £2.5bn Transforming Cities Fund and the Local Growth Fund which has invested over £12bn since 2015, including £141m in the Humber Local Enterprise Partnership.</p><p> </p><p>Over 60% of jobs have been created since 2010 have been in regions outside London and the South East.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 21/05/2019 13:46:00 answering member 4320 label Biography information for Robert Jenrick
	tabling member	1533 label Biography information for Dame Diana Johnson

1127754

	registered interest
	date	21/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Diseases: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what his timescale is for (a) implementing and (b) completing NHS England’s planned restructuring of haemoglobinopathy services; and if he will make a statement.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	256972
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>It is anticipated that NHS England’s new model for specialised haemoglobinopathy services will be in place by early 2020. The new model is designed to improve access to specialist advice and care for patients, irrespective of where they live.</p><p>As part of the new service, NHS England is establishing a National Haemoglobinopathy Panel to provide national multidisciplinary oversight. Patients with complex needs, wherever they live, will be able to be referred to the Panel for expert advice on new treatments and approaches to care. The national service specification will also include guidance for the 13 new born bloodspot screening programme laboratories to refer infants found to be positive for sickle cell disease to the 10 new specialised haemoglobinopathy teams. Whilst NHS England commissions the specialised aspect of haemoglobinopathy care, haemoglobinopathy coordinating centres will be encouraged to link with and support community-based services provided through primary care or community teams based within haemoglobinopathy teams.</p><p>The service specifications for the new specialised haemoglobinopathy teams and the haemoglobinopathy coordinating centres are due to be established in the next month and the associated impact assessment will be published as part of the suite of documents. The equality impact assessment indicates that it will advance the promotion of equality and support the reduction of health inequalities. For example, patients with thalassemia and sickle cell conditions will have equitable access to high quality specialist care and support within specialised commissioned centres irrespective of where in the country they live.</p><p>Hospital Episode Statistics data is attached, showing finished admission episodes with a primary and a primary or secondary diagnosis of sickle cell disorders by NHS England region of residence and Index of Multiple Deprivation decile in the year 2017-18.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 256973 256974 257011 question first answered 04/06/2019 16:13:21 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name Data Table for Combined Diana Johnson PQs (257011) formatted.xlsx title FAE sickle cell NHS England table
	tabling member	1533 label Biography information for Dame Diana Johnson

1127755

	registered interest
	date	21/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of NHS England’s planned restructuring of haemoglobinopathy services on (a) equitable access to services, (b) access to the most effective treatments, (c) access to highly specialised care and (d) quality of care in community-based settings for patients with sickle cell disease.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	256973
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>It is anticipated that NHS England’s new model for specialised haemoglobinopathy services will be in place by early 2020. The new model is designed to improve access to specialist advice and care for patients, irrespective of where they live.</p><p>As part of the new service, NHS England is establishing a National Haemoglobinopathy Panel to provide national multidisciplinary oversight. Patients with complex needs, wherever they live, will be able to be referred to the Panel for expert advice on new treatments and approaches to care. The national service specification will also include guidance for the 13 new born bloodspot screening programme laboratories to refer infants found to be positive for sickle cell disease to the 10 new specialised haemoglobinopathy teams. Whilst NHS England commissions the specialised aspect of haemoglobinopathy care, haemoglobinopathy coordinating centres will be encouraged to link with and support community-based services provided through primary care or community teams based within haemoglobinopathy teams.</p><p>The service specifications for the new specialised haemoglobinopathy teams and the haemoglobinopathy coordinating centres are due to be established in the next month and the associated impact assessment will be published as part of the suite of documents. The equality impact assessment indicates that it will advance the promotion of equality and support the reduction of health inequalities. For example, patients with thalassemia and sickle cell conditions will have equitable access to high quality specialist care and support within specialised commissioned centres irrespective of where in the country they live.</p><p>Hospital Episode Statistics data is attached, showing finished admission episodes with a primary and a primary or secondary diagnosis of sickle cell disorders by NHS England region of residence and Index of Multiple Deprivation decile in the year 2017-18.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 256972 256974 257011 question first answered 04/06/2019 16:13:21 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name Data Table for Combined Diana Johnson PQs (257011) formatted.xlsx title FAE sickle cell NHS England table
	tabling member	1533 label Biography information for Dame Diana Johnson

1127756

	registered interest
	date	21/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will publish impact assessments of the potential effects of NHS England’s planned restructuring of haemoglobinopathy services on treatment of (a) all haemoglobinopathies and (b) sickle cell disease.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	256974
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>It is anticipated that NHS England’s new model for specialised haemoglobinopathy services will be in place by early 2020. The new model is designed to improve access to specialist advice and care for patients, irrespective of where they live.</p><p>As part of the new service, NHS England is establishing a National Haemoglobinopathy Panel to provide national multidisciplinary oversight. Patients with complex needs, wherever they live, will be able to be referred to the Panel for expert advice on new treatments and approaches to care. The national service specification will also include guidance for the 13 new born bloodspot screening programme laboratories to refer infants found to be positive for sickle cell disease to the 10 new specialised haemoglobinopathy teams. Whilst NHS England commissions the specialised aspect of haemoglobinopathy care, haemoglobinopathy coordinating centres will be encouraged to link with and support community-based services provided through primary care or community teams based within haemoglobinopathy teams.</p><p>The service specifications for the new specialised haemoglobinopathy teams and the haemoglobinopathy coordinating centres are due to be established in the next month and the associated impact assessment will be published as part of the suite of documents. The equality impact assessment indicates that it will advance the promotion of equality and support the reduction of health inequalities. For example, patients with thalassemia and sickle cell conditions will have equitable access to high quality specialist care and support within specialised commissioned centres irrespective of where in the country they live.</p><p>Hospital Episode Statistics data is attached, showing finished admission episodes with a primary and a primary or secondary diagnosis of sickle cell disorders by NHS England region of residence and Index of Multiple Deprivation decile in the year 2017-18.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 256972 256973 257011 question first answered 04/06/2019 16:13:21 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name Data Table for Combined Diana Johnson PQs (257011) formatted.xlsx title FAE sickle cell NHS England table
	tabling member	1533 label Biography information for Dame Diana Johnson

1127885

	registered interest
	date	21/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Standards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when he last made an assessment of the effectiveness of key performance indicators for NHS dental practices.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257007
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>NHS England is responsible for the commissioning of dental services and performance management of contracts held. NHS England looks at and update key dental performance indicators as a continuous improvement process. They are prepared by the NHS Business Services Agency and have a formal review annually. The indicators are shared with National Health Service dental providers to assist them in delivering a high quality service to patients. Examples of the information provided can be found on the NHS Business Services Agency website at the following link:</p><p><a href="https://www.nhsbsa.nhs.uk/dental-data" target="_blank">https://www.nhsbsa.nhs.uk/dental-data</a></p><p> </p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 04/06/2019 16:28:20 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1533 label Biography information for Dame Diana Johnson